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Abbreviations 1 
APS - Autoimmune Polyendocrinopathy Syndrome type I 2 
APECED - Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy 3 
AIRE - Autoimmune Regulator 4 
DC - dendritic cell 5 
moDC - monocyte-derived DC 6 
tolDC - tolerogenic moDC 7 
inflDC - inflammatory moDC 8 
mTECs - medullary thymic epithelial cells 9 
eTACs - extrathymic AIRE expressing cells 10 
CMC - chronic mucocutaneous candidiasis 11 
PBMC - peripheral blood mononuclear cells 12 
Dex – dexamethasone 13 
VitD3 – calcitrol 14 
APC - antigen presenting cell 15 
MHC - major histocompatibility complex 16 
PDL-1 - programmed death receptor ligand 1 17 
TLR - toll like receptor 18 
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Summary 1 
Loss-of-function mutations of the Autoimmune Regulator (AIRE) gene result in organ-2 
specific autoimmunity and disease Autoimmune Polyendocrinopathy type 1 (APS1) / 3 
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED). The AIRE 4 
protein is crucial in the induction of central tolerance, promoting ectopic expression of tissue-5 
specific antigens in medullary thymic epithelial cells, enabling removal of self-reactive T-6 
cells. AIRE expression has recently been detected in myeloid dendritic cells (DC), suggesting 7 
AIRE may have a role in peripheral tolerance. DC stimulation of T-cells is critical in 8 
determining the initiation or lack of an immune response, depending on the pattern of 9 
costimulation and cytokine production by DCs, defining immunogenic/inflammatory (inflDC) 10 
and tolerogenic (tolDC) DC. In AIRE-deficient patients and healthy controls we validated the 11 
role of AIRE in the generation and function of monocyte-derived inflDC and tolDCs by 12 
determining mRNA and protein expression of AIRE and comparing activation markers 13 
(HLA-DR/DP/DQ,CD83,CD86,CD274(PDL-1),TLR-2), cytokine production (IL-12p70,IL-14 
10,IL-6,TNF-α,IFN-γ) and T-cell stimulatory capacity (mixed lymphocyte reaction) of 15 
AIRE+ and AIRE- DCs. We show for the first time that: 1) tolDCs from healthy individuals 16 
express AIRE; 2) AIRE expression is not significantly higher in tolDC compared to inflDC; 17 
3) tolDC can be generated from APECED patient monocytes and that 4) tolDCs lacking AIRE 18 
retain the same phenotype and reduced T-cell stimulatory function. Our findings suggest that 19 
AIRE does not have a role in the induction and function of monocyte-derived tolerogenic DC 20 
in humans, but these findings do not exclude a role for AIRE in in peripheral tolerance 21 
mediated by other cell types. 22 
  23 
4 
 
Introduction: 1 
The autoimmune regulator (AIRE) is an important regulator of autoimmunity 2 
promoting central tolerance in the thymus. AIRE is predominantly expressed in thymic 3 
medullary epithelial cells (mTECs), where it promotes the expression of ectopic tissue-4 
specific antigens (1, 2), ensuring the deletion of self-reactive T-cells thus ensuring 5 
immunological tolerance by preventing autoimmunity. 6 
Over 60 autosomal-recessive, loss-of-function mutations within the AIRE gene in 7 
humans described to date underlie the very rare autosomal recessive disease Autoimmune 8 
Polyendocrinopathy Syndrome type 1 (APS1), also called Autoimmune Polyendocrinopathy 9 
Candidiasis Ectodermal Dystrophy (APECED) (OMIM 240300) (3-5). APS1 is typically 10 
characterised by a triad of symptoms including hypoparathyroidism, autoimmune adrenal 11 
insufficiency and chronic mucocutaneous candidiasis (CMC) although other autoimmunity, 12 
both endocrine (diabetes type 1, ovarian, testicular) and non-endocrine (autoimmune 13 
hepatitis) is frequently present. The autoimmunity is consistent with our understanding of the 14 
role of AIRE in the removal of self-reactive T-cells in the thymus but the susceptibility of 15 
APS1 patients to CMC remained elusive and intriguing until recently, when we (6) and others 16 
(7) reported the presence of neutralizing auto-antibodies to interferons type I and Th-17 17 
cytokines (IL-17A, IL-17F and IL-22) in APS1 patient sera. These cytokines are critical for 18 
the protection against fungal infections and neutralizing autoantibodies to these cytokines 19 
elegantly explain the selective susceptibility to fungal infections in APS1 patients in the 20 
context of their autoimmunity. Importantly, the expression of these cytokines, specifically 21 
IFNα, is not restricted to AIRE-expressing mTECS in the thymus (8) suggesting that AIRE 22 
may have additional roles in the periphery in preventing autoimmunity. 23 
The expression of AIRE outside the thymus has been recognised in a number of 24 
human tissues including lymph nodes (9, 10), spleen (10), PBMC (11) and in monocyte-25 
5 
 
dendritic cell lineages (11-14). However, although AIRE gene expression in the periphery is 1 
undisputed, detection of AIRE protein has been and still is far more controversial, especially 2 
in humans (15) (16). 3 
The role of AIRE in the periphery has been confirmed in a number of Aire deficient 4 
(“knock-out”) mouse models, where it was shown that Aire is involved in the 5 
activation/regulation of T-cells. It was shown that splenic and lymph node Aire-/- DC activate 6 
naive T-cells more efficiently than do Aire+/+ DC (17); a splenic population of extrathymic 7 
Aire-expressing cells (eTACs), which were shown to be a bone marrow-derived antigen-8 
presenting cell (APC) population, could directly functionally inactivate CD4+ T-cells (18); 9 
more recently, AIRE was shown to be directly involved in the perinatal generation of 10 
regulatory T-cells crucial for maintain self-tolerance (19). These data indicated that at least in 11 
the mouse model, AIRE may have a regulatory/tolerogenic role in the periphery. 12 
The relevance of findings in AIRE deficient mouse models to the human 13 
APS1/APECED disease has often been questioned as, although Aire-/- mice develop 14 
autoimmunity, they do not develop disease and the repertoire of autoantigens in human 15 
disease and mouse models is poorly replicated (4, 20). To date, there is very little data of 16 
AIRE expression and function in the periphery in humans, particularly in rare APS1 patients 17 
so that this remains an area of substantial interest. Rare studies in humans of extra-thymic 18 
expression have reported AIRE transcript and protein expression in cells of the 19 
monocyte/dendritic lineage (13) and in rare non-conventional lymph node APC (18, 21).  In 20 
APS1 patients we (22) and others (17) previously reported peripheral monocyte-derived 21 
moDC hyperactivation indicating that AIRE may also play a role in peripheral T-cell 22 
activation and thus in tolerance induction in humans. 23 
DC are critical in the initiation of immune responses to invading organisms as well as 24 
induction of central and peripheral tolerance to self-antigens (23). Under steady state, DC 25 
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display an immature phenotype that correlates with low expression of costimulatory 1 
molecules and weak T-cell stimulating properties. Recognition of invading pathogens or local 2 
inflammation induces DC differentiation and maturation, characterized by upregulation of 3 
major histocompatibility (MHC) antigens (signal I), costimulatory molecules (signal II) on the 4 
cell surface and cytokine production (signal III), which are all necessary for the optimal 5 
antigen-specific activation of naïve T-cells. However, presentation of antigen with inadequate 6 
or alternative co-stimulation and cytokine production will result in T-cell silencing, deletion 7 
or T regulatory cell induction. Thus, the pattern of co-stimulation and cytokine production is a 8 
central feature distinguishing immunogenic (inflammatory) and tolerogenic DC (24, 25) and 9 
the differences have been confirmed by distinct mRNA microarray profiles (26). TolDC can 10 
be generated in vitro by a variety of methods which include pharmacologic, biologic and 11 
genetic engineering (27) and have been generated and applied for therapeutic procedures (25). 12 
To better define the role of AIRE in the periphery in humans, we investigated AIRE 13 
expression and function in a model of monocyte-derived (mo)DC differentiated into 14 
tolerogenic (tolDC) and inflammatory (inflDC) and from healthy controls and APS1 patients. 15 
We confirm AIRE expression in moDCs and demonstrate its up-regulation during 16 
differentiation. We show for the first time that: 1) tolDCs from healthy individuals express 17 
AIRE; 2) that AIRE expression is greater in tolDC than inflDC; 3) that tolDC can also be 18 
generated from APECED monocytes and that 4) tolDCs lacking AIRE retain the same 19 
phenotype and in vitro function (i.e. high IL-10 production, low T-cell stimulatory capacity).  20 
 21 
Patients and Methods:  22 
APS1 patient and healthy control samples 23 
This study included seven APS1 patients, all with confirmed AIRE mutations, 5 males and 2 24 
females aged 3-22 years. All patients were homozygous for the 13bp deletion in exon 8 25 
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c.967_979del13, p.(Leu323fs) which is most frequent in the UK (Pearce et al. 1998), apart 1 
from one patient (Pt7) who was a compound heterozygote for c.967_979del13 and c.977C>T. 2 
All patients suffered with CMC, mostly mild as well as hypoparathyroidism, adrenal 3 
insufficiency and hypothyroidism. Patient 5 also had severe autoimmune hepatitis and 4 
malabsorbtion while her brother (patient 6) had only mild CMC at the time of sampling but 5 
later developed autoimmune hepatitis (Table 1). Healthy controls were volunteers or 6 
anonymous donors from the local blood bank and children undergoing general anaesthesia for 7 
non-infectious surgical procedures (ingrown toenails, circumcision etc). Ethical approval was 8 
obtained from the Newcastle and North Tyneside Local Research Ethics Committee under the 9 
Great North Biobank (GNB) (REC No 10/H0906/22) and the Newcastle Autoimmune 10 
Inflammatory Rheumatic Diseases Research (NAIRD) Biobank, (REF No DL-02). 11 
 12 
Isolation and culture of primary cells 13 
Peripheral blood mononuclear cells (PBMC) were isolated by density centrifugation from 14 
peripheral blood or buffy cones of healthy controls and APS1 patients. Monocytes were 15 
positively selected from PBMC using anti-CD14 microbeads (Miltenyi Biotec). CD4 T-cells 16 
were enriched using CD4 RosetteSep (StemCell).  17 
 18 
Generation of monocyte derived DC 19 
Monocyte derived DC (moDC) were differentiated as previously described (28). Briefly, 20 
monocytes were cultured at 0.5x106 cells/ml in the presence of IL-4 and GM-CSF (50 ng/ml 21 
each) (Miltenyi Biotec) for 3 days. On day 3, cells were differentiated into inflammatory 22 
(inflDC) by addition of IL-4 and GM-CSF (50 ng/ml each) or into tolerogenic DC (tolDC) by 23 
addition of IL-4, GM-CSF (50 ng/ml each) and Dexamethasone (10-6 M, Sigma- Aldrich). On 24 
Day 6, all DC were matured by addition of LPS (0.1 μg/mL) (Sigma-Aldrich) for 24h; tolDC 25 
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were additionally treated with addition of dexamethasone (Dex) (10-6M) and calcitriol 1 
(VitD3) (10-10M) (Tocris Bioscience). Cell maturation and differentiation was confirmed by 2 
cell surface marker expression and cytokine production. All DC populations were harvested 3 
on day 7 and washed extensively before use. Cells were cultured in RPMI 1640, 4 
supplemented with 10% FCS, 2 mM glutamine, 100 U/ml penicillin and 100 μg/ml 5 
streptomycin (RF10) at 37°C with 5% CO2. 6 
 7 
DC and T-cell cytokine production and proliferation 8 
Supernatants were harvested 24h after moDC maturation and stored at –20°C. For mixed 9 
lymphocyte reaction (MLR), moDC (1x104) were cultured with 1x105 allogeneic CD4+ T-10 
cells. Supernatants were harvested after 6 days and stored at –20°C. Proliferation was 11 
assessed by incorporation of 3H-thymidine for the last 8h of culture by scintillation counting 12 
(Microbeta TriLux, Perkin Elmer). Cytokines in supernatants (IL-12p70, IL-10, TNF-α, IFN-13 
γ) were quantified using sandwich ELISA (BD Biosciences). 14 
 15 
Flow cytometry 16 
Cell surface expression was investigated using the following anti-human antibodies: HLA-17 
DR/DP/DQ FITC (Tu39), CD83 Allophycocyanin (HB15e), CD274 (PDL-1) FITC (MIH1) 18 
(all BD Pharmingen), CD86 V450 (FUN-1) (BD Horizon) and TLR-2 FITC (TL2.1) 19 
(eBioscience). Cells were acquired on a BD FACSCanto II and analyzed using FlowJo 20 
software (Treestar). 21 
 22 
Western blotting (WB) 23 
Proteins were extracted from cells using RIPA buffer. Equal amounts of proteins were 24 
separated by sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE) using 25 
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12.5% polyacrylamide gel, transferred to polyvinylidene difluoride membranes, and blocked 1 
in 5% milk powder/ 0.05% Tween in Tris-buffered salt solution. Membranes were then 2 
probed with antibodies against AIRE (ab82493) (Abcam) and GAPDH (4134) (Cell 3 
Signalling) overnight at 4°C, followed by HRP-conjugated goat anti-rabbit antibody (Dako, 4 
P0448). Proteins were visualized using the Immobilon Western detection system (Millipore). 5 
AIRE in moDC was identified using human thymus tissue lysate (ab30146) (Abcam) as a 6 
positive control. 7 
 8 
Gene expression PCR 9 
Total RNA was isolated from moDC using RNeasy plus micro kit (Qiagen), according to 10 
manufacturer instruction. Human thymic total RNA (Clontech) was used as a positive control. 11 
cDNA was reverse transcribed from 430ng total RNA using SuperScript III (Invitrogen), 12 
according to manufacturer instruction. cDNA was analysed using semi-quantitative PCR with 13 
Phire Hot Start II DNA polymerase (Thermo Scientific) according to manufacturer protocol. 14 
The following primers were used: AIRE (Fwd 5’AGCAGCCCTGACTCCAAG, Rev 5’ 15 
CCAACCTGGATGCACTTCTT) and GAPDH (Fwd 5’ 16 
GTGAACCATGAGAAGTATGACAAC, Rev 5’ CATGAGTCCTTCCACGATACC ) under 17 
the following cycling conditions: 30s at 98°C, 36 cycles for AIRE or 22 cycles for GAPDH of 18 
98°C for 5s, 60°C for 5s, 72°C for 30s followed by 2m at 72°C. PCR products were 19 
visualized using 1% agarose electrophoresis. 20 
 21 
Statistical analysis and data plotting 22 
Densitometric analysis was performed using ImageJ software. For analysis of AIRE gene and 23 
protein expression, the bands on each agarose gel or western blot were normalized to the 24 
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intensity of the day (D) 7 inflDC sample. Statistical analysis of data was performed with 1 
GraphPad Prism 5.0 using ANOVA with Sidak’s or Tukey’s comparison tests. 2 
 3 
Results: 4 
AIRE is expressed in monocyte-derived dendritic cells 5 
While AIRE gene and protein expression in mice was confirmed in lymph node eTACs, (18), 6 
there is conflicting evidence as to the expression of AIRE protein in monocyte-DC lineages. 7 
Using thymic RNA as a positive control and site specific primers against the canonical AIRE 8 
RNA transcript sequence (NM_000383), we first assessed AIRE gene expression (mRNA). 9 
We confirmed the AIRE transcript in monocytes and moDC (Figure 1A) and contrary to 10 
previous findings (12) demonstrated AIRE mRNA expression to be highest in CD14+ 11 
monocytes (D0), with a modest decrease during moDC differentiation although none of the 12 
changes were statistically significant. In matured DC we confirmed that AIRE is expressed in 13 
inflDC and report for the first time that tolDC also express AIRE mRNA. This expression is 14 
somewhat higher albeit not significantly different compared to inflDC. We next identified 15 
very weak AIRE protein expression in moDC (Figure 1B) and show in healthy controls that 16 
AIRE protein levels increased slightly in mature tolDC and inflDCs compared to CD14+ 17 
monocytes (D0) where protein was undetectable. The level of mRNA transcript did not 18 
correlate with protein expression, and there seemed to be an inverse correlation in that CD14+ 19 
monocyte expressed highest levels of mRNA but no protein was detectable. We did not 20 
attempt AIRE mRNA and protein detection in patients with AIRE deficiency as we do not 21 
expect to find transcript and protein from a non-functional gene. 22 
TolDC can be generated from APS1 patients and retain their tolerogenic phenotype and 23 
function                24 
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To assess whether AIRE has a role in the generation and function of tolDC, we differentiated 1 
inflDC and tolDC from APS1 patients and assessed moDC phenotype and function. Our 2 
results demonstrate that APS1 tolDC exhibit the same characteristics as tolDCs from healthy 3 
individuals in that they maintain high MHC class II expression, have low CD83 and CD86 4 
expression, higher TLR2 expression and lower PD-L1 expression than their inflDC 5 
counterpart (Figure 2A and 2B). Equally, the differences seen in these markers between 6 
inflDC and tolDCs are comparable in healthy controls and APS1 patients. Similar to tolDC 7 
from healthy individuals, APS1 tolDC secrete high levels of IL-10 (Figure 3A). Levels of 8 
TNFα produced by both inflDC and tolDC in both studied groups were comparable while IL-9 
12 production was negligible. APS1 tolDC induced sub-optimal T-cell proliferation (Figure 10 
3B) in a mixed lymphocyte reaction but this did not differ significantly from levels induced 11 
by APS1 inflDCs, as opposed to tolDC generated from healthy individuals. Equally, when 12 
APS1 tolDC are co-cultured with healthy CD4 T-cells, lower levels of IFN-γ and higher 13 
levels of IL-10 are detected compared to inflDC (Figure 3C) and these values are comparable 14 
between healthy controls and APS1 patients. While the generation of InflDC from APS1 15 
patient monocytes has been reported previously (22), we now show that tolDC can also be 16 
generated from APS1 monocytes. These data demonstrate that the functional features of 17 
APS1 tolDC (i.e. high IL-10 production, low T-cell stimulatory capacity) are comparable to 18 
healthy controls, indicating that AIRE is not required for the differentiation or for the 19 
immunosuppressive function of tolDC.         20 
 21 
Discussion and Conclusions: 22 
Although the presence and role of AIRE in thymic medullary epithelial cells (MEC) in 23 
both mice and humans is undisputed, the expression and putative function of AIRE in the 24 
periphery remains controversial (4, 18). While there are several reports confirming AIRE 25 
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protein expression in human thymic DC (29), the consistency of AIRE protein presence in 1 
peripheral human DC is a matter of debate (15). Our results confirm previous reports of AIRE 2 
transcript (mRNA) expression in stimulated moDC (12). We were also able to detect AIRE at 3 
the protein level albeit in very low quantities. When compared to equal quantities of thymic 4 
lysate, it is clear that the expression of AIRE in moDC is substantially lower and consistent 5 
with previous reports of very low/undetectable AIRE protein expression in other immune 6 
cells in the periphery (13). Because of the low expression of AIRE in moDCs our attempts to 7 
silence AIRE in these cells were not reliable (data not shown). We accept that the very low 8 
protein levels detected question the implication of the finding and we acknowledge that 9 
similarly low levels previously reported underpin controversies about its biological 10 
significance, if any. However, band intensities differ and are higher in tolDCs than in their 11 
inflammatory counterpart. In CD14+ monocytes, we detected AIRE transcript which was 12 
actually at its highest level compared to other moDC maturation stages but this did not 13 
correlate with protein expression which was absent, consistent with previous reported findings 14 
of this discrepancy in peripheral cells. Nevertheless, even though we cannot convincingly 15 
demonstrate AIRE protein in DC from healthy controls, we report for the first time that 16 
tolerogenic DCs generated from monocytes isolated from AIRE-deficient patients are 17 
comparable to those generated from healthy controls. Consequently, AIRE is unlikely to play 18 
a role in tolDC generation or in regulating their typical immunosuppressive properties (e.g. 19 
high IL-10 production, low T-cell stimulatory capacity). Having said that, we only 20 
investigated the T-cell stimulatory function of tolDC in an allogeneic setting; it would be 21 
interesting for future studies to use an antigen-specific model so that the antigen-processing 22 
function of tolDC in AIRE-deficient APS-1 patients can be assessed as well. 23 
AIREs putative role in the periphery remains enigmatic. In mice, transcription of 24 
genes that are under Aire control in the thymus differs to those in the periphery (30). AIRE 25 
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expressing APC have been reported to control immune cell function via antigen-specific T-1 
cell suppression (18, 31). Studies in AIRE-/- mice suggest a role for AIRE-expressing DC in 2 
the induction of T-cell tolerance, independent from central tolerance ((17, 20). Several early 3 
reports suggest a role for AIRE in the induction of T-regulatory (Treg) cells in the periphery 4 
(32, 33), while a recent report demonstrates that Aire promotes the perinatal generation of a 5 
distinct compartment of Foxp3+CD4+ T (Treg) cells, which stably persists in adult mice (19). 6 
The few reports investigating AIRE function in peripheral cells of APS1 patients agree 7 
with mice studies showing deregulated DC function and support a role for AIRE in peripheral 8 
tolerance. The eTACs from mice have also been identified in human peripheral lymphoid 9 
tissue (18), yet their tolerogenic function still remains to be confirmed. This is a first study of 10 
AIRE in human tolerogenic DC and shows that AIRE expression is higher in these cells than 11 
in their inflammatory counterpart. However, assessment of typical features of tolDC (i.e. high 12 
IL-10 production, low T-cell stimulatory capacity) in APS1 patients did not confirm a role for 13 
AIRE in this subset of cells, in contrast to other reports of AIRE expressing cells in the 14 
periphery, albeit in mice (15, 18).  15 
There is much intrigue in the similarities, or lack of, between Aire-/- mouse models and 16 
human APS1. Aire-/- mouse models share an autoimmune phenotype with APS1 patients, 17 
although mice mostly do not develop symptoms or have very mild disease depending on the 18 
genetic background (20, 34). Importantly, Aire-/- mice develop autoantibodies to a different 19 
set of self-antigens compared to human patients (35). In mice, autoantibodies to IFN type I 20 
and Th-17 cytokines have only been reported in aged Aire-/- mice on a BALB/c background 21 
(36), yet these mice do not succumb to CMC, These findings may suggest that Aire controls 22 
an alternative set of genes in humans and mice (35) and advocates caution in extrapolating 23 
findings from murine studies to human disease.  24 
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Although we demonstrate that AIRE is not essential for the generation or function of 1 
tolerogenic moDC, we do not discount a role for AIRE in peripheral tolerance. In humans a 2 
distinct DC subset of inflammatory (infl) DC has recently been described which differentiates 3 
from blood monocytes recruited to the site of inflammation (37) and is the likely in vivo 4 
analogue of the in vitro generated moDC. In vitro generated inflDC present antigens, activate 5 
CD4 T-cells and guide cytokine responses depending on environmental cues while tolDCs 6 
induce tolerance through altered presentation of antigen to T-cells and through the production 7 
of suppressive cytokines that inhibit effect T-cell activation (25, 38). As such, moDC/tolDC 8 
were an interesting target to study AIRE and the fact that a role in generation and function 9 
was not found by no means excludes a role for AIRE in other subsets of tolerogenic DC in the 10 
periphery, particularly those subsets where AIRE expression has been documented (10). It is 11 
also possible that AIRE -/- differ from AIRE +/+ tolDCs in ways which were not assessed in 12 
this study such as their transcriptome profile or that AIRE expression may be relevant for 13 
function of other (non-DC) cell types in the periphery as was found in mice (18). To 14 
understand the role of AIRE in the periphery, it is crucial to define how AIRE functions 15 
beyond the expression of ectopic genes in the mTECs as recent data indicate that in the 16 
periphery, AIRE may regulate a large number of genes with different functions (12, 39, 40).   17 
Unexpectedly, it was recently shown that certain heterozygous AIRE mutations may play a 18 
hitherto unrecognised role in common organ-specific autoimmune diseases, suggesting that  19 
our current understanding of its function is still limited (41). In conclusion, our findings 20 
suggest that AIRE does not have a role in the induction and function of monocyte-derived 21 
tolerogenic DC in humans, but these findings do not exclude a role for AIRE in in peripheral 22 
tolerance mediated by other cell types. 23 
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Figure 1. AIRE is expressed in moDC and is higher in TolDC than in InflDC 1 
Monocytes from healthy controls were cultured with IL-4 / GM-CSF to produce inflDC (Infl) 2 
and additionally with Dex for tolDC (Tol). At day 6 moDC were matured with LPS for inflDC 3 
and additionally with VitD3 and Dex for tolDC. At the given timepoints, cells were harvested 4 
for RNA extraction for (A) PCR or lysed for (B) Western blot analysis. For densitometry 5 
analysis, band intensities were first normalised to D7 InflDC for each gene/protein, then 6 
AIRE band intensities were normalised to each GAPDH band for every time point. Graphs 7 
illustrate the mean + SEM of 5 independent experiments. One-way ANOVA analysis with 8 
Sidak’s multiple comparison test was performed. ns = not significant, *p<0.05, **p<0.01, 9 
***p<0.005, ****p<0.001. 10 
 11 
 12 
Figure 2. TolDC can be generated from APS1 patient monocytes and have a tolerogenic 13 
phenotype  14 
Monocytes from healthy controls or APS1 patients were cultured with IL-4 / GM-CSF to 15 
produce inflDC (Infl) and additionally with Dex for tolDC (Tol). At day 6 moDC were 16 
matured with LPS for inflDC and additionally with VitD3 and Dex for tolDC. (A) moDC 17 
were stained for the cell surface markers (MHC classII, CD83, CD86, TLR-2 and PDL-1) and 18 
analyzed by flow cytometry. A comparison of median fluorescence intensity (MFI) between a 19 
sample from a healthy control and APS1 patients is shown in (A). In (B) a summary of 20 
individual results is shown for all healthy control and patient samples. Graphs illustrate 21 
individual values and mean values with number of experiments shown on graph. One-way 22 
ANOVA analysis with Tukey’s multiple comparison test was performed. ns = not significant, 23 
*p<0.05, **p<0.01, ***p<0.005, ****p<0.001. 24 
 25 
 26 
24 
 
 1 
Figure 3. TolDC generated from APS1 patient monocytes show cytokine production and 2 
a mixed lymphocyte reaction (MLR) consistent with a tolerogenic function. (A) Culture 3 
supernatants were taken on D7 and assayed for the cytokines shown, by ELISA. (B) MoDC 4 
were co-cultured with allogeneic CD4+ T-cells in a an MLR for 6 days.  Proliferation was 5 
assessed by 3H incorporation. (C) MLR culture supernatants were taken at D6 and assayed 6 
for the given cytokines, by ELISA. Graphs illustrate individual values and mean values with 7 
number of experiments shown on graph. One-way ANOVA analysis with Tukey’s multiple 8 
comparison test was performed. ns = not significant, *p<0.05, **p<0.01, ***p<0.005, 9 
****p<0.001. 10 
 11 
